semaglutide bone loss GLP-1s and Health: What the Evidence Says About Semaglutide, Bone Density, and Muscle Weight loss induced bone loss:

Mixed centrally and peripherally acting anti-obesity medicines with evidence for use in older adults Three GLP-1 receptor agonists are currently approved for obesity pharmacotherapy (Tirzepatide is a dual GIP-GLP-1 receptor agonist)

It achieves this massive accumulation of monoamines through a combination of several synergistic mechanisms at the presynaptic nerve terminal (Figure 2)

Because organosulfur compounds derived from alliinase-catalyzed reactions may play a role in some of the biological effects of garlic, some scientists recommend that crushed or chopped garlic be allowed to "stand" for at least 10 minutes prior to cooking (135)

GLP-1 Agonists in Type 1 DiabetesIndications and Use